Previous work in muscle, lymphoma and HeLa cells have shown that miR-26a and miR-26b can negatively regulate EZH2 expression, and that this occurs via binding to the highly conserved predicted miR-26a/b binding site within the 3′ UTR of EZH2 [21-23]. This evidence concerns the gene EZH2 and lymphoma.